Buys | $0 | 0 | 0 |
Sells | $13,954,663 | 117 | 100 |
Egbuonu-Davis Lisa | director | 0 | $0 | 1 | $32,239 | $-32,239 |
Hui Yvonne | Principal Accounting Officer | 0 | $0 | 9 | $133,645 | $-133,645 |
Smith Mark Douglas | director | 0 | $0 | 1 | $175,000 | $-175,000 |
Gunzburg Janet | Principal Accounting Officer | 0 | $0 | 7 | $200,537 | $-200,537 |
VanDuyn Amy Beth | SVP, Human Resources | 0 | $0 | 11 | $1.03M | $-1.03M |
Weintraub Michael | director | 0 | $0 | 4 | $1.32M | $-1.32M |
Hoffman Allison C | General Counsel & Secretary | 0 | $0 | 15 | $1.79M | $-1.79M |
Linetsky David | SVP, Life Sciences | 0 | $0 | 28 | $1.84M | $-1.84M |
Gandhi Balaji | Chief Financial Officer | 0 | $0 | 14 | $1.98M | $-1.98M |
Indig Chaim | Chief Executive Officer | 0 | $0 | 10 | $2.14M | $-2.14M |
Roberts Evan | Chief Operating Officer | 0 | $0 | 17 | $3.31M | $-3.31M |
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and …
Over the last 12 months, insiders at Phreesia, Inc. have bought $0 and sold $13.95M worth of Phreesia, Inc. stock.
On average, over the past 5 years, insiders at Phreesia, Inc. have bought $0 and sold $29.28M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
2025-02-19 | Sale | Roberts Evan | Chief Operating Officer | 177 0.0003% | $30.00 | $5,310 | -13.03% | |
2025-02-19 | Sale | Gandhi Balaji | Chief Financial Officer | 96 0.0002% | $30.00 | $2,880 | -13.03% | |
2025-02-18 | Sale | Roberts Evan | Chief Operating Officer | 3,519 0.0061% | $30.06 | $105,764 | -14.61% | |
2025-02-18 | Sale | Hoffman Allison C | General Counsel & Secretary | 3,496 0.006% | $29.72 | $103,901 | -14.61% | |
2025-02-18 | Sale | Gandhi Balaji | Chief Financial Officer | 5,771 0.01% | $30.04 | $173,377 | -14.61% | |
2025-02-14 | Sale | Roberts Evan | Chief Operating Officer | 3,586 0.0062% | $30.13 | $108,039 | -13.54% | |
2025-02-14 | Sale | Gandhi Balaji | Chief Financial Officer | 4,889 0.0084% | $30.09 | $147,089 | -13.54% | |
2025-02-13 | Sale | Roberts Evan | Chief Operating Officer | 16,005 0.0291% | $30.00 | $480,152 | -12.86% | |
2025-02-13 | Sale | Linetsky David | SVP, Life Sciences | 11,616 0.0209% | $29.70 | $345,001 | -12.86% | |
2025-02-13 | Sale | Gandhi Balaji | Chief Financial Officer | 28,759 0.0522% | $30.00 | $862,770 | -12.86% | |
2025-02-07 | Sale | Linetsky David | SVP, Life Sciences | 300 0.0005% | $29.52 | $8,857 | -7.56% | |
2025-02-05 | Sale | Linetsky David | SVP, Life Sciences | 720 0.0013% | $29.50 | $21,241 | -6.59% | |
2025-01-29 | Sale | Linetsky David | SVP, Life Sciences | 500 0.0009% | $29.68 | $14,841 | -2.09% | |
2025-01-28 | Sale | Hoffman Allison C | General Counsel & Secretary | 6,235 0.0105% | $28.50 | $177,698 | -3.43% | |
2025-01-27 | Sale | Indig Chaim | Chief Executive Officer | 26,248 0.0461% | $27.48 | $721,198 | +5.49% | |
2025-01-27 | Sale | Roberts Evan | Chief Operating Officer | 10,716 0.0188% | $27.48 | $294,436 | +5.49% | |
2025-01-27 | Sale | Linetsky David | SVP, Life Sciences | 11,685 0.0205% | $27.48 | $321,060 | +5.49% | |
2025-01-27 | Sale | Hoffman Allison C | General Counsel & Secretary | 6,556 0.0115% | $27.48 | $180,135 | +5.49% | |
2025-01-27 | Sale | Gandhi Balaji | Chief Financial Officer | 4,813 0.0085% | $27.48 | $132,244 | +5.49% | |
2025-01-27 | Sale | VanDuyn Amy Beth | SVP, Human Resources | 3,475 0.0061% | $27.48 | $95,480 | +5.49% |
Increased Positions | 96 | +44.86% | 5M | +8.02% |
Decreased Positions | 92 | -42.99% | 5M | -8.85% |
New Positions | 28 | New | 854,163 | New |
Sold Out Positions | 28 | Sold Out | 2M | Sold Out |
Total Postitions | 218 | +1.87% | 57M | -0.83% |
Fmr Llc | $163,293.00 | 10.61% | 6.15M | -544,669 | -8.13% | 2024-12-31 |
Brown Advisory Inc | $148,480.00 | 9.65% | 5.59M | -91,534 | -1.61% | 2024-12-31 |
Blackrock, Inc. | $140,036.00 | 9.1% | 5.28M | +35,872 | +0.69% | 2024-12-31 |
Vanguard Group Inc | $128,005.00 | 8.32% | 4.82M | +61,048 | +1.28% | 2024-12-31 |
Greenhouse Funds Lllp | $76,273.00 | 4.96% | 2.87M | +626,579 | +27.88% | 2024-12-31 |
Capital International Investors | $68,820.00 | 4.47% | 2.59M | 0 | 0% | 2024-12-31 |
Champlain Investment Partners, Llc | $65,186.00 | 4.24% | 2.46M | -47,688 | -1.91% | 2024-12-31 |
Rock Springs Capital Management Lp | $54,142.00 | 3.52% | 2.04M | -242,500 | -10.62% | 2024-12-31 |
Credit Suisse Ag/ | $46,997.00 | 3.05% | 1.77M | -7,464 | -0.42% | 2024-03-31 |
Franklin Resources Inc | $40,065.00 | 2.6% | 1.51M | +11,986 | +0.8% | 2024-12-31 |